To Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With Sickle Cell Disease

Clinical trial NCT04134299 · COMPLETED

Trial details

NCT number: NCT04134299
Sponsor: Axcella Health, Inc
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

To Assess the Safety and Tolerabiltiy of an Amino Acid Composition in Subjects With Sickle Cell Disease Anemia, Sickle Cell Sickle Cell Anemia Sickle Cell Disorders Sickle Cell Disease

Start date: 2019-09-25
Primary completion: 2021-01-11
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.